Smoking and the platelet fibrinogen receptor glycoprotein IIb/IIIA PlA1/A2 polymorphism interact in the risk of lacunar stroke and midterm survival

Stroke

Volumn 38, Issue 1, 2007, Pages 50-55

  Oksala, Niku K J ^a,c   Heikkinen, Maarit ^a   Mikkelsson, Jussi ^a   Pohjasvaara, Tarja ^b   Kaste, Markku ^b   Erkinjuntti, Timo ^b   Karhunen, Pekka J ^a,c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Polymorphisms; Smoking; Stroke; Survival

Indexed keywords

FIBRINOGEN; FIBRINOGEN RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DEATH; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; STROKE; SURVIVAL; THROMBOCYTE;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BRAIN INFARCTION; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; FINLAND; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; SMOKING; SURVIVAL RATE;

EID: 33845933039     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000251719.59141.36     Document Type: Article

References (29)

1. Salonen JT, Puska P, Tuomilehto J, Homan K. Relation of blood pressure, serum lipids, and smoking to the risk of cerebral stroke: a longitudinal study in Eastern Finland. Stroke. 1982;13:327-333.
2. Berger K, Schulte H, Stogbauer F, Assmann G. Incidence and risk factors for stroke in an occupational cohort: the PROCAM Study: Prospective Cardiovascular Muenster Study. Stroke. 1998;29:1562-1566.
3. Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, van Harskamp F, Tanghe HL, de Jong PT, van Gijn J, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994;44:1246-1252.
4. Balleisen L, Assmann G, Bailey J, Epping PH, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population, II: baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions. Thromb Haemost. 1985;54:721-723.
5. Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex: results from the second MONICA Augsburg survey 1989-1990. Arterioscler Thromb. 1992;12:780-788.
6. Thomas AE, Green FR, Humphries SE. Association of genetic variation at the β-fibrinogen gene locus and plasma fibrinogen levels: interaction between allele frequency of the G/A-455 polymorphism, age and smoking. Clin Genet. 1996;50:184-190.
7. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Cigarette smoking among spouses: another risk factor for stroke in women. Stroke. 2005;36:e74-e76.
8. Ueshima H, Choudhury SR, Okayama A, Hayakawa T, Kita Y, Kadowaki T, Okamura T, Minowa M, Iimura O. Cigarette smoking as a risk factor for stroke death in Japan: NIPPON DATA80. Stroke. 2004;35:1836-1841.
9. Mannami T, Iso H, Baba S, Sasaki S, Okada K, Konishi M, Tsugane S. Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women: the JPHC Study Cohort I. Stroke. 2004;35:1248-1253.
10. Rothwell PM, Howard SC, Power DA, Gutnikov SA, Algra A, van Gijn J, Clark TG, Murphy MF, Warlow CP. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke. 2004;35:2300-2305.
11. Carter AM, Catto AJ, Bamford JM, Grant PJ. Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol. 1998;18:1124-1131.
12. Yip HK, Liou CW, Chang HW, Lan MY, Liu JS, Chen MC. Link between platelet activity and outcomes after an ischemic stroke. Cerebrovasc Dis. 2005;20:120-128.
13. Martiskainen M, Pohjasvaara T, Mikkelsson J, Mantyla R, Kunnas T, Laippala P, Ilveskoski E, Kaste M, Karhunen PJ, Erkinjuntti E. Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke. Stroke. 2003;34:886-891.
14. Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest. 1989;83:1778-1781.
15. A polymorphisms display different sensitivities to agonists. Circulation. 2000;101:1013-1018.
16. PlA polymorphism and aspirin resistance: is there any correlation? Ann Pharmacother. 2005;39:1013-1018.
17. Wagner KR, Giles WH, Johnson CJ, Ou CY, Bray PF, Goldschmidt-Clermont PJ, Croft JB, Brown VK, Stern BJ, Feeser BR, Buchholz DW, Earley CJ, Macko RF, McCarter RJ, Sloan MA, Stolley PD, Wityk RJ, Wozniak MA, Price TR, Kittner SJ. Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study. Stroke. 1998;29:581-585.
18. Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet. 1997;349:385-388.
19. Carlsson LE, Greinacher A, Spitzer C, Walther R, Kessler C. Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke. 1997;28:1392-1395.
20. Lopes NH, Pereira AC, Hueb W, Soares PR, Lanz JR, Gersh BJ, de Oliveira S, Cesar LA, Ramires JF, Krieger JE. Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking. Am J Cardiol. 2004;93:1469-1472.
21. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M. Comparison of stroke features and disability in daily life in patients with ischemic stroke aged 55 to 70 and 71 to 85 years. Stroke. 1997;28:729-735.
22. Mantyla R, Aronen HJ, Salonen O, Pohjasvaara T, Korpelainen M, Peltonen T, Standertskjold-Nordenstam CG, Kaste M, Erkinjuntti T. Magnetic resonance imaging white matter hyperintensities and mechanism of ischemic stroke. Stroke. 1999;30:2053-2058.
23. Pohjasvaara T, Mantyla R, Salonen O, Aronen HJ, Ylikoski R, Hietanen M, Kaste M, Erkinjuntti T. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol. 2000;57:1295-1300.
24. Mikkelsson J, Perola M, Laippala P, Savolainen V, Pajarinen J, Lalu K, Penttila A, Karhunen PJ. Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arterioscler Thromb Vasc Biol. 1999;19:2573-2578.
25. A1/A2 polymorphism and sudden cardiac death. J Am Coll Cardiol. 2000;36:1317-1323.
26. Grove EL, Orntoft TF, Lassen JF, Jensen HK, Kristensen SD. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction. J Intern Med. 2004;255:637-644.
27. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Bene J, Havasi V, Komlosi K, Melegh B. Increased prevalence of platelet glycoprotein IIb/IIIa PLA2 allele in ischaemic stroke associated with large vessel pathology. Thromb Res. 2003;109:265-269.
28. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 1996;334:1090-1094.
29. A2 allele of the platelet glycoprotein IIIa gene. Eur Heart J. 2001;22:587-595.